GI Tract

An Immune Culprit in IBD?

Patients with Crohn’s disease or ulcerative colitis have reduced levels of an important regulator of the immune response—the receptor for granulocyte-macrophage colony-stimulating factor (GM-CSF)—according to a study by Jonathan Goldstein et al. in the July issue of Gastroenterology. The inflammatory bowel diseases (IBD) ulcerative colitis and Crohn’s disease arise from

Read more

Constipation Relief

The drug bisacodyl is effective against chronic constipation and improves patients’ quality of life, according to a large study published by Michael Kamm et al. in the July issue of Clinical Gastroenterology and Hepatology. Constipation affects 12% to 19% of Americans; its prevalence increases with age and it affects women

Read more

Causes of Chronic Nausea and Vomiting

Chronic nausea and vomiting in patients with normal gastric emptying is a significant medical problem that is indistinguishable from gastroparesis and might be a separate clinical entity, according to Pankaj Pasricha in the July issue of Clinical Gastroenterology and Hepatology. Chronic nausea and vomiting in patients that do not have

Read more

Does Mucosal Healing Determine Which Patients Will Recover From Ulcerative Colitis?

Lack of mucosal healing, based on endoscopic analysis, identifies patients with ulcerative colitis (UC) who are not likely to respond to corticosteroid therapy, according to Sandro Ardizzone et al. in the June issue of Clinical Gastroenterology and Hepatology. In a prospective study, Ardizzone et al. followed 157 patients with moderate

Read more

Who Will Develop Colorectal Cancer at a Young Age?

A screen for mutations in mismatch repair (MMR) genes could be used to identify young people at risk for colorectal cancer, report Paul Limburg et al. in the June issue of Clinical Gastroenterology and Hepatology. It is a challenge to identify people who are less than 50 years old that

Read more

Tracking Crohn’s Therapy

Measuring blood levels of C-reactive protein (CRP), a marker of inflammation, is a good way to monitor recovery from Crohn’s disease (CD) in patients being treated with infliximab, according to Matthias Jürgens et al. in the May issue of Clinical Gastroenterology and Hepatology. CRP is a protein released into the blood

Read more

Surviving Childhood Cancer Increases GI Risks

Individuals who received therapy for cancer during childhood have an increased risk of developing GI complications later in life, according to Robert Goldsby et al. in the May issue of Gastroenterology. About 80% of children who receive cancer therapy survive more than 5 years; therapies can be especially toxic to

Read more

H Pylori—Are They Gone Yet?

Helicobacter pylori infection can be treated with proton pump inhibitors (PPIs) and antibiotics, but physicians need ways to determine if the bacteria are completely eradicated months later. In the May issue of Clinical Gastroenterology and Hepatology, Luigi Gatta et al. describe a simple blood test that can detect H pylori

Read more

Colon Complications from Anti-Inflammatory Drugs?

Aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) are known to cause stomach problems, but a large prospective study by Lisa Strate et al. in the May issue of Gastroenterology shows that they can also damage the colon, causing diverticulitis and diverticular bleeding. Strate et al. tracked the use of aspirin,

Read more

What is the Best Strategy for Children with Celiac Disease?

Most children with potential celiac disease, based on serologic markers, remain healthy after 3 years—only about a third develop villous atrophy, report Antonella Tosco et al. in the April issue of Clinical Gastroenterology and Hepatology. However, antibody tests can identify children at greatest risk for the changes in the intestinal

Read more